Navin fluorine commences 15k mtpa hfc expansion

Navin Fluorine commenced commercial operations for its additional 15,000 MTPA HFC (R32) capacity at its Surat unit. This ₹236.50 crore expansion follows a stellar Q2 FY27 where net profit surged 82% YoY to ₹269 crore on 57% revenue growth to ₹1,191 crore. The new HFC capacity is slated for progressive ramp-up, directly targeting the growing global demand for next-generation, lower-global-warming-potential refrigerants. This matters because it diversifies the company's revenue beyond traditional agrochemical and pharma CDMO segments into high-volume, specialized fluorine chemistry. I am watching the Q3 FY27 earnings call in January 2027 for the exact capacity utilization rate of this Surat facility and the sequential EBITDA margin trajectory, which already expanded to an impressive 34.2% in Q2. The market currently prices Navin Fluorine purely on its legacy CDMO order book, viewing new greenfield capex as a distant, margin-dilutive distraction. What the consensus misses is the structural operating leverage this specific HFC expansion enables. Step one: R32 is a high-demand refrigerant, commanding sticky, premium pricing power over commoditized legacy chemicals. Step two: funding this ₹236.50 crore project while delivering an 82% profit surge proves exceptional internal cash generation without balance sheet debt drag. Step three: this vertically integrates their fluorine value chain, creating a captive, high-margin revenue stream insulated from agrochemical cyclical downturns. The market misprices this as routine capacity addition, ignoring the compounding return on capital employed (ROCE) from a highly specialized, globally competitive chemical platform. Accumulate for long-term specialty chemical margin expansion. Disclosure: I do not hold positions in this stock. This is for educational purposes only and does not constitute investment advice. NAVINFLUOR